Literature DB >> 18679060

Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports.

Wouter L Curvers1, Femke P Peters, Brenda Elzer, Annet J C M Schaap, Lubbertus C Baak, Arnoud van Oijen, Rosalie M Mallant-Hent, Fiebo Ten Kate, Kausilia K Krishnadath, Jacques J G H M Bergman.   

Abstract

OBJECTIVE: The quality of Barrett's surveillance relies on an adequate endoscopic inspection, obtaining a sufficient number of biopsy specimens, good communication of the endoscopic findings to the pathologist, and an accurate description of the histological findings by the pathologist. The aim of this study was to assess the quality of Barrett's surveillance in daily practice in The Netherlands.
MATERIALS AND METHODS: A structured scoring list was developed to evaluate systematically the quality of endoscopy and pathology reports. From 15 hospitals, endoscopy reports and corresponding pathology reports were selected randomly and evaluated by two observers. In case of disagreement, the observers re-evaluated the reports in a consensus meeting.
RESULTS: One hundred and fifty cases were evaluated. The adherence to current standard biopsy protocols (four quadrant biopsies every 2 cm) decreased with increasing Barrett's length: 0-5 cm: 79%; 5-10 cm: 50%; 10-15 cm: 30%. The indication for the endoscopy was mentioned in 28% of the pathology reports, in 4% the presence/absence of oesophagitis was communicated, and in 19% the location and/or aetiology of biopsies was described. The presence/absence of dysplasia was mentioned in 93% of pathology reports.
CONCLUSION: Endoscopy reports and pathology reports in current practice do not include all relevant information for an adequate Barrett's surveillance. In short Barrett's oesophagus, the adherence to current standard biopsy protocols is acceptable, but in longer segments (with a higher risk for neoplastic progression) this is clearly insufficient. The communication between endoscopists and pathologist is suboptimal.

Entities:  

Mesh:

Year:  2008        PMID: 18679060     DOI: 10.1097/MEG.0b013e3282f8295d

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  23 in total

1.  From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett's Esophagus.

Authors:  J Brown; P Sharma
Journal:  Dig Dis Sci       Date:  2016-01       Impact factor: 3.199

Review 2.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

3.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

Review 4.  Low grade dysplasia in Barrett's esophagus: Should we worry?

Authors:  Vamshi P Jagadesham; Clive J Kelty
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

5.  Inter-endoscopist agreement in diagnosis of Barrett's oesophagus.

Authors:  Glen A Doherty; Danny G Cheriyan; Jan E Leyden; John F O'Dowd; Frank E Murray; Stephen E Patchett
Journal:  Frontline Gastroenterol       Date:  2011-03-20

6.  Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma.

Authors:  S Eluri; E Klaver; L C Duits; S A Jackson; J J Bergman; N J Shaheen
Journal:  Dis Esophagus       Date:  2018-11-01       Impact factor: 3.429

7.  Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?

Authors:  Arianna Barbetta; Shahdabul Faraz; Pari Shah; Hans Gerdes; Meier Hsu; Kay See Tan; Tamar Nobel; Manjit S Bains; Matthew Bott; James M Isbell; David B Sewell; David R Jones; Daniela Molena
Journal:  J Gastrointest Surg       Date:  2018-03-05       Impact factor: 3.452

Review 8.  Past, present and future of Barrett's oesophagus.

Authors:  W K Tan; M di Pietro; R C Fitzgerald
Journal:  Eur J Surg Oncol       Date:  2017-02-16       Impact factor: 4.424

Review 9.  Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk.

Authors:  Kerry B Dunbar; Rhonda F Souza
Journal:  Gastrointest Endosc Clin N Am       Date:  2017-07

10.  Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.

Authors:  Kavel Visrodia; Prasad G Iyer; Cathy D Schleck; Alan R Zinsmeister; David A Katzka
Journal:  Dig Dis Sci       Date:  2015-05-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.